Medical Care
Global Blood Product Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 06, 25
- ID: 288753
- Pages: 155
- Figures: 158
- Views: 6
In 2024, the global market size of Blood Product was estimated to be worth US$ 35330 million and is forecast to reach approximately US$ 58200 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Blood Products are medical products derived from human blood and used for the treatment of various conditions. They include whole blood, blood components like red blood cells, platelets, and plasma, as well as plasma derivatives such as clotting factors and immunoglobulins. Blood products are essential in medical treatments, including surgeries, trauma care, and for patients with blood disorders, anemia, or immune deficiencies.
Market Drivers:
Increasing Demand for Plasma-Derived Therapies: The rising prevalence of chronic diseases, such as immune deficiencies, hemophilia, and autoimmune disorders, has led to increased demand for plasma-derived products like immunoglobulins, clotting factors, and albumin, driving the Plasma Fractionation Technology market.
Aging Population: The global aging population is more prone to chronic diseases and conditions requiring plasma-derived therapies, contributing to the growth of the Plasma Fractionation Technologyation market.
Growing Use of Immunoglobulins: Immunoglobulins are increasingly used in the treatment of a wide range of diseases, including primary and secondary immune deficiencies, boosting the need for Plasma Fractionation Technology to produce these therapies.
Rising Healthcare Expenditure and Improved Healthcare Access: Expanding healthcare infrastructure in developing countries, combined with rising healthcare expenditure, is driving demand for advanced medical treatments and plasma-derived products.
Market Challenges:
High Costs of Plasma-Derived Products: The complex and time-consuming process of Plasma Fractionation Technologyation leads to high costs for plasma-derived products, making these treatments less accessible, particularly in low-income regions.
Limited Plasma Supply: The availability of plasma for fractionation is often limited by low donation rates, regulatory restrictions, and the lengthy process of screening and collecting plasma, leading to supply shortages.
Stringent Regulatory Framework: Plasma Fractionation Technologyation is subject to rigorous regulatory requirements to ensure safety and efficacy. Meeting these regulations can increase development costs and slow the introduction of new products to the market.
Complex Manufacturing Process: The Plasma Fractionation Technologyation process is technically challenging and requires significant investment in infrastructure, equipment, and skilled labor, posing barriers for new entrants and smaller manufacturers.
The outbreak of COVID-19 pandemic has led to decrease in number of blood donations and plasma collections, which hampers the market growth as it leads to shortage in raw material supply.
The classification of Plasma Fractionation Technology includes Immune Globulin, Coagulation Factor, Albumin and Other. In 2023, Immune Globulin accounted for a share of 51% in the global Plasma Fractionation Technology market.
North America is the largest consumption place, with a revenue market share nearly 40% in 2023. Following North America, Europe is the second largest consumption place with the revenue market share of 24 %; China is also an important sales region for the Plasma Fractionation Technology.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Blood Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Product.
The Blood Product market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Blood Product market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Product companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Nanyue Bio
KM Biologics
Segment by Type
Albumin
Immunoglobulin
Clotting Factor
Others
Segment by Application
Hospital
Retail Pharmacy
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Blood Product in global and regional level.
Chapter 3: Detailed analysis of Blood Product company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Blood Product revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Blood Products are medical products derived from human blood and used for the treatment of various conditions. They include whole blood, blood components like red blood cells, platelets, and plasma, as well as plasma derivatives such as clotting factors and immunoglobulins. Blood products are essential in medical treatments, including surgeries, trauma care, and for patients with blood disorders, anemia, or immune deficiencies.
Market Drivers:
Increasing Demand for Plasma-Derived Therapies: The rising prevalence of chronic diseases, such as immune deficiencies, hemophilia, and autoimmune disorders, has led to increased demand for plasma-derived products like immunoglobulins, clotting factors, and albumin, driving the Plasma Fractionation Technology market.
Aging Population: The global aging population is more prone to chronic diseases and conditions requiring plasma-derived therapies, contributing to the growth of the Plasma Fractionation Technologyation market.
Growing Use of Immunoglobulins: Immunoglobulins are increasingly used in the treatment of a wide range of diseases, including primary and secondary immune deficiencies, boosting the need for Plasma Fractionation Technology to produce these therapies.
Rising Healthcare Expenditure and Improved Healthcare Access: Expanding healthcare infrastructure in developing countries, combined with rising healthcare expenditure, is driving demand for advanced medical treatments and plasma-derived products.
Market Challenges:
High Costs of Plasma-Derived Products: The complex and time-consuming process of Plasma Fractionation Technologyation leads to high costs for plasma-derived products, making these treatments less accessible, particularly in low-income regions.
Limited Plasma Supply: The availability of plasma for fractionation is often limited by low donation rates, regulatory restrictions, and the lengthy process of screening and collecting plasma, leading to supply shortages.
Stringent Regulatory Framework: Plasma Fractionation Technologyation is subject to rigorous regulatory requirements to ensure safety and efficacy. Meeting these regulations can increase development costs and slow the introduction of new products to the market.
Complex Manufacturing Process: The Plasma Fractionation Technologyation process is technically challenging and requires significant investment in infrastructure, equipment, and skilled labor, posing barriers for new entrants and smaller manufacturers.
The outbreak of COVID-19 pandemic has led to decrease in number of blood donations and plasma collections, which hampers the market growth as it leads to shortage in raw material supply.
The classification of Plasma Fractionation Technology includes Immune Globulin, Coagulation Factor, Albumin and Other. In 2023, Immune Globulin accounted for a share of 51% in the global Plasma Fractionation Technology market.
North America is the largest consumption place, with a revenue market share nearly 40% in 2023. Following North America, Europe is the second largest consumption place with the revenue market share of 24 %; China is also an important sales region for the Plasma Fractionation Technology.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Blood Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Product.
The Blood Product market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Blood Product market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Product companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Nanyue Bio
KM Biologics
Segment by Type
Albumin
Immunoglobulin
Clotting Factor
Others
Segment by Application
Hospital
Retail Pharmacy
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Blood Product in global and regional level.
Chapter 3: Detailed analysis of Blood Product company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Blood Product revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
1 Study Coverage
1.1 Blood Product Product Introduction
1.2 Market by Type
1.2.1 Global Blood Product Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Albumin
1.2.3 Immunoglobulin
1.2.4 Clotting Factor
1.2.5 Others
1.3 Market by Application
1.3.1 Global Blood Product Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Blood Product Market Size Estimates and Forecasts
2.2 Blood Product Market Size by Region: 2024 Versus 2031
2.2.1 Global Blood Product Revenue by Region: 2020-2025
2.2.2 Global Blood Product Revenue Forecast by Region (2026-2031)
2.2.3 Global Blood Product Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Blood Product Revenue by Type (2020-2031)
3.1.2 Global Blood Product Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Blood Product Revenue by Application (2020-2031)
3.2.2 Global Blood Product Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Albumin of Blood Product Revenue Market Share by Application
3.3.2 Immunoglobulin of Blood Product Revenue Market Share by Application
3.3.3 Clotting Factor of Blood Product Revenue Market Share by Application
3.3.4 Others of Blood Product Revenue Market Share by Application
4 Global Blood Product by Company
4.1 Global Blood Product Revenue by Company (2020-2025)
4.2 Global Blood Product Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Blood Product Companies around the World: Ranking by Revenue
4.3.2 Global Blood Product Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Blood Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Blood Product Companies Headquarters & Product Type
4.4.1 Global Blood Product Companies Headquarters
4.4.2 Date of International Companies Enter into Blood Product Market
4.4.3 Global Blood Product Companies Product & Service
4.4.4 Albumin Revenue Market Share of Blood Product by Company
4.4.5 Immunoglobulin Revenue Market Share of Blood Product by Company
4.4.6 Clotting Factor Revenue Market Share of Blood Product by Company
4.4.7 Others Revenue Market Share of Blood Product by Company
4.5 Global Blood Product Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Takeda
5.1.1 Takeda Corporation Information
5.1.2 Takeda Description, Business Overview
5.1.3 Takeda Blood Product Products Offered
5.1.4 Takeda Blood Product Revenue and Gross Margin (2020-2025)
5.1.5 Takeda Blood Product Revenue by Product in 2024
5.1.6 Takeda Blood Product Revenue by Application in 2024
5.1.7 Takeda Blood Product Revenue by Geographic Area in 2024
5.1.8 Takeda Recent Developments
5.2 CSL
5.2.1 CSL Corporation Information
5.2.2 CSL Description, Business Overview
5.2.3 CSL Blood Product Products Offered
5.2.4 CSL Blood Product Revenue and Gross Margin (2020-2025)
5.2.5 CSL Blood Product Revenue by Product in 2024
5.2.6 CSL Blood Product Revenue by Application in 2024
5.2.7 CSL Blood Product Revenue by Geographic Area in 2024
5.2.8 CSL Recent Developments
5.3 Grifols
5.3.1 Grifols Corporation Information
5.3.2 Grifols Description, Business Overview
5.3.3 Grifols Blood Product Products Offered
5.3.4 Grifols Blood Product Revenue and Gross Margin (2020-2025)
5.3.5 Grifols Blood Product Revenue by Product in 2024
5.3.6 Grifols Blood Product Revenue by Application in 2024
5.3.7 Grifols Blood Product Revenue by Geographic Area in 2024
5.3.8 Grifols Recent Developments
5.4 Octapharma
5.4.1 Octapharma Corporation Information
5.4.2 Octapharma Description, Business Overview
5.4.3 Octapharma Blood Product Products Offered
5.4.4 Octapharma Blood Product Revenue and Gross Margin (2020-2025)
5.4.5 Octapharma Blood Product Revenue by Product in 2024
5.4.6 Octapharma Blood Product Revenue by Application in 2024
5.4.7 Octapharma Blood Product Revenue by Geographic Area in 2024
5.4.8 Octapharma Recent Developments
5.5 Kedrion
5.5.1 Kedrion Corporation Information
5.5.2 Kedrion Description, Business Overview
5.5.3 Kedrion Blood Product Products Offered
5.5.4 Kedrion Blood Product Revenue and Gross Margin (2020-2025)
5.5.5 Kedrion Blood Product Revenue by Product in 2024
5.5.6 Kedrion Blood Product Revenue by Application in 2024
5.5.7 Kedrion Blood Product Revenue by Geographic Area in 2024
5.5.8 Kedrion Recent Developments
5.6 LFB Group
5.6.1 LFB Group Corporation Information
5.6.2 LFB Group Description, Business Overview
5.6.3 LFB Group Blood Product Products Offered
5.6.4 LFB Group Blood Product Revenue and Gross Margin (2020-2025)
5.6.5 LFB Group Blood Product Revenue by Product in 2024
5.6.6 LFB Group Blood Product Revenue by Application in 2024
5.6.7 LFB Group Blood Product Revenue by Geographic Area in 2024
5.6.8 LFB Group Recent Developments
5.7 Biotest
5.7.1 Biotest Corporation Information
5.7.2 Biotest Description, Business Overview
5.7.3 Biotest Blood Product Products Offered
5.7.4 Biotest Blood Product Revenue and Gross Margin (2020-2025)
5.7.5 Biotest Blood Product Revenue by Product in 2024
5.7.6 Biotest Blood Product Revenue by Application in 2024
5.7.7 Biotest Blood Product Revenue by Geographic Area in 2024
5.7.8 Biotest Recent Developments
5.8 BPL
5.8.1 BPL Corporation Information
5.8.2 BPL Description, Business Overview
5.8.3 BPL Blood Product Products Offered
5.8.4 BPL Blood Product Revenue and Gross Margin (2020-2025)
5.8.5 BPL Blood Product Revenue by Product in 2024
5.8.6 BPL Blood Product Revenue by Application in 2024
5.8.7 BPL Blood Product Revenue by Geographic Area in 2024
5.8.8 BPL Recent Developments
5.9 RAAS
5.9.1 RAAS Corporation Information
5.9.2 RAAS Description, Business Overview
5.9.3 RAAS Blood Product Products Offered
5.9.4 RAAS Blood Product Revenue and Gross Margin (2020-2025)
5.9.5 RAAS Blood Product Revenue by Product in 2024
5.9.6 RAAS Blood Product Revenue by Application in 2024
5.9.7 RAAS Blood Product Revenue by Geographic Area in 2024
5.9.8 RAAS Recent Developments
5.10 CBPO
5.10.1 CBPO Corporation Information
5.10.2 CBPO Description, Business Overview
5.10.3 CBPO Blood Product Products Offered
5.10.4 CBPO Blood Product Revenue and Gross Margin (2020-2025)
5.10.5 CBPO Blood Product Revenue by Product in 2024
5.10.6 CBPO Blood Product Revenue by Application in 2024
5.10.7 CBPO Blood Product Revenue by Geographic Area in 2024
5.10.8 CBPO Recent Developments
5.11 Hualan Bio
5.11.1 Hualan Bio Corporation Information
5.11.2 Hualan Bio Description, Business Overview
5.11.3 Hualan Bio Blood Product Products Offered
5.11.4 Hualan Bio Blood Product Revenue and Gross Margin (2020-2025)
5.11.5 Hualan Bio Blood Product Revenue by Product in 2024
5.11.6 Hualan Bio Blood Product Revenue by Application in 2024
5.11.7 Hualan Bio Blood Product Revenue by Geographic Area in 2024
5.11.8 Hualan Bio Recent Developments
5.12 Tiantan Bio
5.12.1 Tiantan Bio Corporation Information
5.12.2 Tiantan Bio Description, Business Overview
5.12.3 Tiantan Bio Blood Product Products Offered
5.12.4 Tiantan Bio Blood Product Revenue and Gross Margin (2020-2025)
5.12.5 Tiantan Bio Blood Product Revenue by Product in 2024
5.12.6 Tiantan Bio Blood Product Revenue by Application in 2024
5.12.7 Tiantan Bio Blood Product Revenue by Geographic Area in 2024
5.12.8 Tiantan Bio Recent Developments
5.13 Shuanglin Bio
5.13.1 Shuanglin Bio Corporation Information
5.13.2 Shuanglin Bio Description, Business Overview
5.13.3 Shuanglin Bio Blood Product Products Offered
5.13.4 Shuanglin Bio Blood Product Revenue and Gross Margin (2020-2025)
5.13.5 Shuanglin Bio Blood Product Revenue by Product in 2024
5.13.6 Shuanglin Bio Blood Product Revenue by Application in 2024
5.13.7 Shuanglin Bio Blood Product Revenue by Geographic Area in 2024
5.13.8 Shuanglin Bio Recent Developments
5.14 Boya Bio
5.14.1 Boya Bio Corporation Information
5.14.2 Boya Bio Description, Business Overview
5.14.3 Boya Bio Blood Product Products Offered
5.14.4 Boya Bio Blood Product Revenue and Gross Margin (2020-2025)
5.14.5 Boya Bio Blood Product Revenue by Product in 2024
5.14.6 Boya Bio Blood Product Revenue by Application in 2024
5.14.7 Boya Bio Blood Product Revenue by Geographic Area in 2024
5.14.8 Boya Bio Recent Developments
5.15 Yuanda Shuyang
5.15.1 Yuanda Shuyang Corporation Information
5.15.2 Yuanda Shuyang Description, Business Overview
5.15.3 Yuanda Shuyang Blood Product Products Offered
5.15.4 Yuanda Shuyang Blood Product Revenue and Gross Margin (2020-2025)
5.15.5 Yuanda Shuyang Blood Product Revenue by Product in 2024
5.15.6 Yuanda Shuyang Blood Product Revenue by Application in 2024
5.15.7 Yuanda Shuyang Blood Product Revenue by Geographic Area in 2024
5.15.8 Yuanda Shuyang Recent Developments
5.16 Weiguang Bio
5.16.1 Weiguang Bio Corporation Information
5.16.2 Weiguang Bio Description, Business Overview
5.16.3 Weiguang Bio Blood Product Products Offered
5.16.4 Weiguang Bio Blood Product Revenue and Gross Margin (2020-2025)
5.16.5 Weiguang Bio Blood Product Revenue by Product in 2024
5.16.6 Weiguang Bio Blood Product Revenue by Application in 2024
5.16.7 Weiguang Bio Blood Product Revenue by Geographic Area in 2024
5.16.8 Weiguang Bio Recent Developments
5.17 Nanyue Bio
5.17.1 Nanyue Bio Corporation Information
5.17.2 Nanyue Bio Description, Business Overview
5.17.3 Nanyue Bio Blood Product Products Offered
5.17.4 Nanyue Bio Blood Product Revenue and Gross Margin (2020-2025)
5.17.5 Nanyue Bio Blood Product Revenue by Product in 2024
5.17.6 Nanyue Bio Blood Product Revenue by Application in 2024
5.17.7 Nanyue Bio Blood Product Revenue by Geographic Area in 2024
5.17.8 Nanyue Bio Recent Developments
5.18 KM Biologics
5.18.1 KM Biologics Corporation Information
5.18.2 KM Biologics Description, Business Overview
5.18.3 KM Biologics Blood Product Products Offered
5.18.4 KM Biologics Blood Product Revenue and Gross Margin (2020-2025)
5.18.5 KM Biologics Blood Product Revenue by Product in 2024
5.18.6 KM Biologics Blood Product Revenue by Application in 2024
5.18.7 KM Biologics Blood Product Revenue by Geographic Area in 2024
5.18.8 KM Biologics Recent Developments
6 North America
6.1 North America Blood Product Market Size YoY Growth 2020-2031
6.2 North America Blood Product Market Facts & Figures by Country (2020-2031)
6.3 North America Blood Product Revenue by Type (2020-2025)
6.4 North America Blood Product Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Blood Product Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Blood Product Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Blood Product Revenue by Type (2020-2025)
7.4 Asia-Pacific Blood Product Revenue by Application (2020-2025)
8 Europe
8.1 Europe Blood Product Market Size YoY Growth 2020-2031
8.2 Europe Blood Product Market Facts & Figures by Country (2020-2031)
8.3 Europe Blood Product Revenue by Type (2020-2025)
8.4 Europe Blood Product Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Blood Product Market Size YoY Growth 2020-2031
9.2 Latin America Blood Product Market Facts & Figures by Country (2020-2031)
9.3 Latin America Blood Product Revenue by Type (2020-2025)
9.4 Latin America Blood Product Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Blood Product Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Blood Product Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Blood Product Revenue by Type (2020-2025)
10.4 Middle East and Africa Blood Product Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Blood Product Supply Chain Analysis
11.2 Blood Product Key Raw Materials and Upstream Suppliers
11.3 Blood Product Clients Analysis
11.4 Blood Product Sales Channel and Sales Model Analysis
11.4.1 Blood Product Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Blood Product Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Blood Product Distributors
12 Blood Product Market Dynamics
12.1 Blood Product Industry Trends
12.2 Blood Product Market Drivers
12.3 Blood Product Market Challenges
12.4 Blood Product Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Blood Product Product Introduction
1.2 Market by Type
1.2.1 Global Blood Product Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Albumin
1.2.3 Immunoglobulin
1.2.4 Clotting Factor
1.2.5 Others
1.3 Market by Application
1.3.1 Global Blood Product Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Blood Product Market Size Estimates and Forecasts
2.2 Blood Product Market Size by Region: 2024 Versus 2031
2.2.1 Global Blood Product Revenue by Region: 2020-2025
2.2.2 Global Blood Product Revenue Forecast by Region (2026-2031)
2.2.3 Global Blood Product Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Blood Product Revenue by Type (2020-2031)
3.1.2 Global Blood Product Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Blood Product Revenue by Application (2020-2031)
3.2.2 Global Blood Product Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Albumin of Blood Product Revenue Market Share by Application
3.3.2 Immunoglobulin of Blood Product Revenue Market Share by Application
3.3.3 Clotting Factor of Blood Product Revenue Market Share by Application
3.3.4 Others of Blood Product Revenue Market Share by Application
4 Global Blood Product by Company
4.1 Global Blood Product Revenue by Company (2020-2025)
4.2 Global Blood Product Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Blood Product Companies around the World: Ranking by Revenue
4.3.2 Global Blood Product Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Blood Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Blood Product Companies Headquarters & Product Type
4.4.1 Global Blood Product Companies Headquarters
4.4.2 Date of International Companies Enter into Blood Product Market
4.4.3 Global Blood Product Companies Product & Service
4.4.4 Albumin Revenue Market Share of Blood Product by Company
4.4.5 Immunoglobulin Revenue Market Share of Blood Product by Company
4.4.6 Clotting Factor Revenue Market Share of Blood Product by Company
4.4.7 Others Revenue Market Share of Blood Product by Company
4.5 Global Blood Product Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Takeda
5.1.1 Takeda Corporation Information
5.1.2 Takeda Description, Business Overview
5.1.3 Takeda Blood Product Products Offered
5.1.4 Takeda Blood Product Revenue and Gross Margin (2020-2025)
5.1.5 Takeda Blood Product Revenue by Product in 2024
5.1.6 Takeda Blood Product Revenue by Application in 2024
5.1.7 Takeda Blood Product Revenue by Geographic Area in 2024
5.1.8 Takeda Recent Developments
5.2 CSL
5.2.1 CSL Corporation Information
5.2.2 CSL Description, Business Overview
5.2.3 CSL Blood Product Products Offered
5.2.4 CSL Blood Product Revenue and Gross Margin (2020-2025)
5.2.5 CSL Blood Product Revenue by Product in 2024
5.2.6 CSL Blood Product Revenue by Application in 2024
5.2.7 CSL Blood Product Revenue by Geographic Area in 2024
5.2.8 CSL Recent Developments
5.3 Grifols
5.3.1 Grifols Corporation Information
5.3.2 Grifols Description, Business Overview
5.3.3 Grifols Blood Product Products Offered
5.3.4 Grifols Blood Product Revenue and Gross Margin (2020-2025)
5.3.5 Grifols Blood Product Revenue by Product in 2024
5.3.6 Grifols Blood Product Revenue by Application in 2024
5.3.7 Grifols Blood Product Revenue by Geographic Area in 2024
5.3.8 Grifols Recent Developments
5.4 Octapharma
5.4.1 Octapharma Corporation Information
5.4.2 Octapharma Description, Business Overview
5.4.3 Octapharma Blood Product Products Offered
5.4.4 Octapharma Blood Product Revenue and Gross Margin (2020-2025)
5.4.5 Octapharma Blood Product Revenue by Product in 2024
5.4.6 Octapharma Blood Product Revenue by Application in 2024
5.4.7 Octapharma Blood Product Revenue by Geographic Area in 2024
5.4.8 Octapharma Recent Developments
5.5 Kedrion
5.5.1 Kedrion Corporation Information
5.5.2 Kedrion Description, Business Overview
5.5.3 Kedrion Blood Product Products Offered
5.5.4 Kedrion Blood Product Revenue and Gross Margin (2020-2025)
5.5.5 Kedrion Blood Product Revenue by Product in 2024
5.5.6 Kedrion Blood Product Revenue by Application in 2024
5.5.7 Kedrion Blood Product Revenue by Geographic Area in 2024
5.5.8 Kedrion Recent Developments
5.6 LFB Group
5.6.1 LFB Group Corporation Information
5.6.2 LFB Group Description, Business Overview
5.6.3 LFB Group Blood Product Products Offered
5.6.4 LFB Group Blood Product Revenue and Gross Margin (2020-2025)
5.6.5 LFB Group Blood Product Revenue by Product in 2024
5.6.6 LFB Group Blood Product Revenue by Application in 2024
5.6.7 LFB Group Blood Product Revenue by Geographic Area in 2024
5.6.8 LFB Group Recent Developments
5.7 Biotest
5.7.1 Biotest Corporation Information
5.7.2 Biotest Description, Business Overview
5.7.3 Biotest Blood Product Products Offered
5.7.4 Biotest Blood Product Revenue and Gross Margin (2020-2025)
5.7.5 Biotest Blood Product Revenue by Product in 2024
5.7.6 Biotest Blood Product Revenue by Application in 2024
5.7.7 Biotest Blood Product Revenue by Geographic Area in 2024
5.7.8 Biotest Recent Developments
5.8 BPL
5.8.1 BPL Corporation Information
5.8.2 BPL Description, Business Overview
5.8.3 BPL Blood Product Products Offered
5.8.4 BPL Blood Product Revenue and Gross Margin (2020-2025)
5.8.5 BPL Blood Product Revenue by Product in 2024
5.8.6 BPL Blood Product Revenue by Application in 2024
5.8.7 BPL Blood Product Revenue by Geographic Area in 2024
5.8.8 BPL Recent Developments
5.9 RAAS
5.9.1 RAAS Corporation Information
5.9.2 RAAS Description, Business Overview
5.9.3 RAAS Blood Product Products Offered
5.9.4 RAAS Blood Product Revenue and Gross Margin (2020-2025)
5.9.5 RAAS Blood Product Revenue by Product in 2024
5.9.6 RAAS Blood Product Revenue by Application in 2024
5.9.7 RAAS Blood Product Revenue by Geographic Area in 2024
5.9.8 RAAS Recent Developments
5.10 CBPO
5.10.1 CBPO Corporation Information
5.10.2 CBPO Description, Business Overview
5.10.3 CBPO Blood Product Products Offered
5.10.4 CBPO Blood Product Revenue and Gross Margin (2020-2025)
5.10.5 CBPO Blood Product Revenue by Product in 2024
5.10.6 CBPO Blood Product Revenue by Application in 2024
5.10.7 CBPO Blood Product Revenue by Geographic Area in 2024
5.10.8 CBPO Recent Developments
5.11 Hualan Bio
5.11.1 Hualan Bio Corporation Information
5.11.2 Hualan Bio Description, Business Overview
5.11.3 Hualan Bio Blood Product Products Offered
5.11.4 Hualan Bio Blood Product Revenue and Gross Margin (2020-2025)
5.11.5 Hualan Bio Blood Product Revenue by Product in 2024
5.11.6 Hualan Bio Blood Product Revenue by Application in 2024
5.11.7 Hualan Bio Blood Product Revenue by Geographic Area in 2024
5.11.8 Hualan Bio Recent Developments
5.12 Tiantan Bio
5.12.1 Tiantan Bio Corporation Information
5.12.2 Tiantan Bio Description, Business Overview
5.12.3 Tiantan Bio Blood Product Products Offered
5.12.4 Tiantan Bio Blood Product Revenue and Gross Margin (2020-2025)
5.12.5 Tiantan Bio Blood Product Revenue by Product in 2024
5.12.6 Tiantan Bio Blood Product Revenue by Application in 2024
5.12.7 Tiantan Bio Blood Product Revenue by Geographic Area in 2024
5.12.8 Tiantan Bio Recent Developments
5.13 Shuanglin Bio
5.13.1 Shuanglin Bio Corporation Information
5.13.2 Shuanglin Bio Description, Business Overview
5.13.3 Shuanglin Bio Blood Product Products Offered
5.13.4 Shuanglin Bio Blood Product Revenue and Gross Margin (2020-2025)
5.13.5 Shuanglin Bio Blood Product Revenue by Product in 2024
5.13.6 Shuanglin Bio Blood Product Revenue by Application in 2024
5.13.7 Shuanglin Bio Blood Product Revenue by Geographic Area in 2024
5.13.8 Shuanglin Bio Recent Developments
5.14 Boya Bio
5.14.1 Boya Bio Corporation Information
5.14.2 Boya Bio Description, Business Overview
5.14.3 Boya Bio Blood Product Products Offered
5.14.4 Boya Bio Blood Product Revenue and Gross Margin (2020-2025)
5.14.5 Boya Bio Blood Product Revenue by Product in 2024
5.14.6 Boya Bio Blood Product Revenue by Application in 2024
5.14.7 Boya Bio Blood Product Revenue by Geographic Area in 2024
5.14.8 Boya Bio Recent Developments
5.15 Yuanda Shuyang
5.15.1 Yuanda Shuyang Corporation Information
5.15.2 Yuanda Shuyang Description, Business Overview
5.15.3 Yuanda Shuyang Blood Product Products Offered
5.15.4 Yuanda Shuyang Blood Product Revenue and Gross Margin (2020-2025)
5.15.5 Yuanda Shuyang Blood Product Revenue by Product in 2024
5.15.6 Yuanda Shuyang Blood Product Revenue by Application in 2024
5.15.7 Yuanda Shuyang Blood Product Revenue by Geographic Area in 2024
5.15.8 Yuanda Shuyang Recent Developments
5.16 Weiguang Bio
5.16.1 Weiguang Bio Corporation Information
5.16.2 Weiguang Bio Description, Business Overview
5.16.3 Weiguang Bio Blood Product Products Offered
5.16.4 Weiguang Bio Blood Product Revenue and Gross Margin (2020-2025)
5.16.5 Weiguang Bio Blood Product Revenue by Product in 2024
5.16.6 Weiguang Bio Blood Product Revenue by Application in 2024
5.16.7 Weiguang Bio Blood Product Revenue by Geographic Area in 2024
5.16.8 Weiguang Bio Recent Developments
5.17 Nanyue Bio
5.17.1 Nanyue Bio Corporation Information
5.17.2 Nanyue Bio Description, Business Overview
5.17.3 Nanyue Bio Blood Product Products Offered
5.17.4 Nanyue Bio Blood Product Revenue and Gross Margin (2020-2025)
5.17.5 Nanyue Bio Blood Product Revenue by Product in 2024
5.17.6 Nanyue Bio Blood Product Revenue by Application in 2024
5.17.7 Nanyue Bio Blood Product Revenue by Geographic Area in 2024
5.17.8 Nanyue Bio Recent Developments
5.18 KM Biologics
5.18.1 KM Biologics Corporation Information
5.18.2 KM Biologics Description, Business Overview
5.18.3 KM Biologics Blood Product Products Offered
5.18.4 KM Biologics Blood Product Revenue and Gross Margin (2020-2025)
5.18.5 KM Biologics Blood Product Revenue by Product in 2024
5.18.6 KM Biologics Blood Product Revenue by Application in 2024
5.18.7 KM Biologics Blood Product Revenue by Geographic Area in 2024
5.18.8 KM Biologics Recent Developments
6 North America
6.1 North America Blood Product Market Size YoY Growth 2020-2031
6.2 North America Blood Product Market Facts & Figures by Country (2020-2031)
6.3 North America Blood Product Revenue by Type (2020-2025)
6.4 North America Blood Product Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Blood Product Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Blood Product Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Blood Product Revenue by Type (2020-2025)
7.4 Asia-Pacific Blood Product Revenue by Application (2020-2025)
8 Europe
8.1 Europe Blood Product Market Size YoY Growth 2020-2031
8.2 Europe Blood Product Market Facts & Figures by Country (2020-2031)
8.3 Europe Blood Product Revenue by Type (2020-2025)
8.4 Europe Blood Product Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Blood Product Market Size YoY Growth 2020-2031
9.2 Latin America Blood Product Market Facts & Figures by Country (2020-2031)
9.3 Latin America Blood Product Revenue by Type (2020-2025)
9.4 Latin America Blood Product Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Blood Product Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Blood Product Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Blood Product Revenue by Type (2020-2025)
10.4 Middle East and Africa Blood Product Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Blood Product Supply Chain Analysis
11.2 Blood Product Key Raw Materials and Upstream Suppliers
11.3 Blood Product Clients Analysis
11.4 Blood Product Sales Channel and Sales Model Analysis
11.4.1 Blood Product Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Blood Product Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Blood Product Distributors
12 Blood Product Market Dynamics
12.1 Blood Product Industry Trends
12.2 Blood Product Market Drivers
12.3 Blood Product Market Challenges
12.4 Blood Product Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Blood Product Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Blood Product Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Blood Product Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Blood Product Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Blood Product Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Blood Product Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Blood Product Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Blood Product Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Blood Product Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Blood Product Revenue by Company (2020-2025) & (US$ Million)
Table 11. Blood Product Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Blood Product Players by Revenue (US$ Million) in 2024
Table 13. Global Blood Product Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Blood Product by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Product as of 2024)
Table 15. Global Blood Product Companies Headquarters
Table 16. Date of International Companies Enter into Blood Product Market
Table 17. Global Blood Product Companies Product & Service
Table 18. Global Blood Product Mergers & Acquisitions, Expansion Plans
Table 19. Takeda Corporation Information
Table 20. Takeda Description and Business Overview
Table 21. Takeda Blood Product Product
Table 22. Takeda Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Takeda Revenue Proportion of Blood Product by Product in 2024
Table 24. Takeda Revenue Proportion of Blood Product by Application in 2024
Table 25. Takeda Revenue Proportion of Blood Product by Geographic Area in 2024
Table 26. Takeda Recent Developments
Table 27. CSL Corporation Information
Table 28. CSL Description and Business Overview
Table 29. CSL Blood Product Product
Table 30. CSL Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. CSL Revenue Proportion of Blood Product by Product in 2024
Table 32. CSL Revenue Proportion of Blood Product by Application in 2024
Table 33. CSL Revenue Proportion of Blood Product by Geographic Area in 2024
Table 34. CSL Recent Developments
Table 35. Grifols Corporation Information
Table 36. Grifols Description and Business Overview
Table 37. Grifols Blood Product Product
Table 38. Grifols Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Grifols Revenue Proportion of Blood Product by Product in 2024
Table 40. Grifols Revenue Proportion of Blood Product by Application in 2024
Table 41. Grifols Revenue Proportion of Blood Product by Geographic Area in 2024
Table 42. Grifols Recent Developments
Table 43. Octapharma Corporation Information
Table 44. Octapharma Description and Business Overview
Table 45. Octapharma Blood Product Product
Table 46. Octapharma Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Octapharma Revenue Proportion of Blood Product by Product in 2024
Table 48. Octapharma Revenue Proportion of Blood Product by Application in 2024
Table 49. Octapharma Revenue Proportion of Blood Product by Geographic Area in 2024
Table 50. Octapharma Recent Developments
Table 51. Kedrion Corporation Information
Table 52. Kedrion Description and Business Overview
Table 53. Kedrion Blood Product Product
Table 54. Kedrion Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Kedrion Revenue Proportion of Blood Product by Product in 2024
Table 56. Kedrion Revenue Proportion of Blood Product by Application in 2024
Table 57. Kedrion Revenue Proportion of Blood Product by Geographic Area in 2024
Table 58. Kedrion Recent Developments
Table 59. LFB Group Corporation Information
Table 60. LFB Group Description and Business Overview
Table 61. LFB Group Blood Product Product
Table 62. LFB Group Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. LFB Group Revenue Proportion of Blood Product by Product in 2024
Table 64. LFB Group Revenue Proportion of Blood Product by Application in 2024
Table 65. LFB Group Revenue Proportion of Blood Product by Geographic Area in 2024
Table 66. LFB Group Recent Developments
Table 67. Biotest Corporation Information
Table 68. Biotest Description and Business Overview
Table 69. Biotest Blood Product Product
Table 70. Biotest Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Biotest Revenue Proportion of Blood Product by Product in 2024
Table 72. Biotest Revenue Proportion of Blood Product by Application in 2024
Table 73. Biotest Revenue Proportion of Blood Product by Geographic Area in 2024
Table 74. Biotest Recent Developments
Table 75. BPL Corporation Information
Table 76. BPL Description and Business Overview
Table 77. BPL Blood Product Product
Table 78. BPL Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. BPL Revenue Proportion of Blood Product by Product in 2024
Table 80. BPL Revenue Proportion of Blood Product by Application in 2024
Table 81. BPL Revenue Proportion of Blood Product by Geographic Area in 2024
Table 82. BPL Recent Developments
Table 83. RAAS Corporation Information
Table 84. RAAS Description and Business Overview
Table 85. RAAS Blood Product Product
Table 86. RAAS Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. RAAS Revenue Proportion of Blood Product by Product in 2024
Table 88. RAAS Revenue Proportion of Blood Product by Application in 2024
Table 89. RAAS Revenue Proportion of Blood Product by Geographic Area in 2024
Table 90. RAAS Recent Developments
Table 91. CBPO Corporation Information
Table 92. CBPO Description and Business Overview
Table 93. CBPO Blood Product Product
Table 94. CBPO Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. CBPO Revenue Proportion of Blood Product by Product in 2024
Table 96. CBPO Revenue Proportion of Blood Product by Application in 2024
Table 97. CBPO Revenue Proportion of Blood Product by Geographic Area in 2024
Table 98. CBPO Recent Developments
Table 99. Hualan Bio Corporation Information
Table 100. Hualan Bio Description and Business Overview
Table 101. Hualan Bio Blood Product Product
Table 102. Hualan Bio Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Hualan Bio Revenue Proportion of Blood Product by Product in 2024
Table 104. Hualan Bio Revenue Proportion of Blood Product by Application in 2024
Table 105. Hualan Bio Revenue Proportion of Blood Product by Geographic Area in 2024
Table 106. Hualan Bio Recent Developments
Table 107. Tiantan Bio Corporation Information
Table 108. Tiantan Bio Description and Business Overview
Table 109. Tiantan Bio Blood Product Product
Table 110. Tiantan Bio Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. Tiantan Bio Revenue Proportion of Blood Product by Product in 2024
Table 112. Tiantan Bio Revenue Proportion of Blood Product by Application in 2024
Table 113. Tiantan Bio Revenue Proportion of Blood Product by Geographic Area in 2024
Table 114. Tiantan Bio Recent Developments
Table 115. Shuanglin Bio Corporation Information
Table 116. Shuanglin Bio Description and Business Overview
Table 117. Shuanglin Bio Blood Product Product
Table 118. Shuanglin Bio Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. Shuanglin Bio Revenue Proportion of Blood Product by Product in 2024
Table 120. Shuanglin Bio Revenue Proportion of Blood Product by Application in 2024
Table 121. Shuanglin Bio Revenue Proportion of Blood Product by Geographic Area in 2024
Table 122. Shuanglin Bio Recent Developments
Table 123. Boya Bio Corporation Information
Table 124. Boya Bio Description and Business Overview
Table 125. Boya Bio Blood Product Product
Table 126. Boya Bio Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
Table 127. Boya Bio Revenue Proportion of Blood Product by Product in 2024
Table 128. Boya Bio Revenue Proportion of Blood Product by Application in 2024
Table 129. Boya Bio Revenue Proportion of Blood Product by Geographic Area in 2024
Table 130. Boya Bio Recent Developments
Table 131. Yuanda Shuyang Corporation Information
Table 132. Yuanda Shuyang Description and Business Overview
Table 133. Yuanda Shuyang Blood Product Product
Table 134. Yuanda Shuyang Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
Table 135. Yuanda Shuyang Revenue Proportion of Blood Product by Product in 2024
Table 136. Yuanda Shuyang Revenue Proportion of Blood Product by Application in 2024
Table 137. Yuanda Shuyang Revenue Proportion of Blood Product by Geographic Area in 2024
Table 138. Yuanda Shuyang Recent Developments
Table 139. Weiguang Bio Corporation Information
Table 140. Weiguang Bio Description and Business Overview
Table 141. Weiguang Bio Blood Product Product
Table 142. Weiguang Bio Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. Weiguang Bio Revenue Proportion of Blood Product by Product in 2024
Table 144. Weiguang Bio Revenue Proportion of Blood Product by Application in 2024
Table 145. Weiguang Bio Revenue Proportion of Blood Product by Geographic Area in 2024
Table 146. Weiguang Bio Recent Developments
Table 147. Nanyue Bio Corporation Information
Table 148. Nanyue Bio Description and Business Overview
Table 149. Nanyue Bio Blood Product Product
Table 150. Nanyue Bio Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
Table 151. Nanyue Bio Revenue Proportion of Blood Product by Product in 2024
Table 152. Nanyue Bio Revenue Proportion of Blood Product by Application in 2024
Table 153. Nanyue Bio Revenue Proportion of Blood Product by Geographic Area in 2024
Table 154. Nanyue Bio Recent Developments
Table 155. KM Biologics Corporation Information
Table 156. KM Biologics Description and Business Overview
Table 157. KM Biologics Blood Product Product
Table 158. KM Biologics Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
Table 159. KM Biologics Revenue Proportion of Blood Product by Product in 2024
Table 160. KM Biologics Revenue Proportion of Blood Product by Application in 2024
Table 161. KM Biologics Revenue Proportion of Blood Product by Geographic Area in 2024
Table 162. KM Biologics Recent Developments
Table 163. North America Blood Product Revenue by Country (2020-2025) & (US$ Million)
Table 164. North America Blood Product Revenue by Country (2026-2031) & (US$ Million)
Table 165. North America Blood Product Revenue by Type (2020-2025) & (US$ Million)
Table 166. North America Blood Product Revenue by Application (2020-2025) & (US$ Million)
Table 167. Asia-Pacific Blood Product Revenue by Region (2020-2025) & (US$ Million)
Table 168. Asia-Pacific Blood Product Revenue by Region (2026-2031) & (US$ Million)
Table 169. Asia-Pacific Blood Product Revenue by Type (2020-2025) & (US$ Million)
Table 170. Asia-Pacific Blood Product Revenue by Application (2020-2025) & (US$ Million)
Table 171. Europe Blood Product Revenue by Country (2020-2025) & (US$ Million)
Table 172. Europe Blood Product Revenue by Country (2026-2031) & (US$ Million)
Table 173. Europe Blood Product Revenue by Type (2020-2025) & (US$ Million)
Table 174. Europe Blood Product Revenue by Application (2020-2025) & (US$ Million)
Table 175. Latin America Blood Product Revenue by Country (2020-2025) & (US$ Million)
Table 176. Latin America Blood Product Revenue by Country (2026-2031) & (US$ Million)
Table 177. Latin America Blood Product Revenue by Type (2020-2025) & (US$ Million)
Table 178. Latin America Blood Product Revenue by Application (2020-2025) & (US$ Million)
Table 179. Middle East and Africa Blood Product Revenue by Country (2020-2025) & (US$ Million)
Table 180. Middle East and Africa Blood Product Revenue by Country (2026-2031) & (US$ Million)
Table 181. Middle East and Africa Blood Product Revenue by Type (2020-2025) & (US$ Million)
Table 182. Middle East and Africa Blood Product Revenue by Application (2020-2025) & (US$ Million)
Table 183. Blood Product Key Raw Materials, Industry Status and Trend
Table 184. Blood Product Key Raw Materials and Upstream Suppliers
Table 185. Blood Product Clients Status and Trend
Table 186. Blood Product Typical Clients
Table 187. Blood Product Distributors
Table 188. Blood Product Market Trends
Table 189. Blood Product Market Drivers
Table 190. Blood Product Market Challenges
Table 191. Blood Product Market Restraints
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
List of Figures
Figure 1. Blood Product Product Picture
Figure 2. Global Blood Product Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Blood Product Revenue Market Share by Type in 2024 & 2031
Figure 4. Albumin Product Picture
Figure 5. Immunoglobulin Product Picture
Figure 6. Clotting Factor Product Picture
Figure 7. Others Product Picture
Figure 8. Global Blood Product Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 9. Global Blood Product Revenue Market Share by Application in 2024 & 2031
Figure 10. Hospital
Figure 11. Retail Pharmacy
Figure 12. Other
Figure 13. Blood Product Report Years Considered
Figure 14. Global Blood Product Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Blood Product Market Size (2020-2031) & (US$ Million)
Figure 16. Global Blood Product Market Size Market Share by Region: 2024 Versus 2031
Figure 17. Global Blood Product Revenue Market Share by Region (2020-2031)
Figure 18. Global Blood Product Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Global Blood Product Revenue Market Share Forecast by Application (2020-2031)
Figure 20. Albumin of Blood Product Revenue Market Share by Application, 2024 VS 2031
Figure 21. Immunoglobulin of Blood Product Revenue Market Share by Application, 2024 VS 2031
Figure 22. Clotting Factor of Blood Product Revenue Market Share by Application, 2024 VS 2031
Figure 23. Others of Blood Product Revenue Market Share by Application, 2024 VS 2031
Figure 24. Blood Product Revenue Share by Company (2024)
Figure 25. Blood Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. Albumin Revenue Proportion by Company in 2024
Figure 27. Immunoglobulin Revenue Proportion by Company in 2024
Figure 28. Clotting Factor Revenue Proportion by Company in 2024
Figure 29. Others Revenue Proportion by Company in 2024
Figure 30. North America Blood Product Revenue 2020-2031 (US$ Million)
Figure 31. North America Blood Product Revenue Market Share by Type (2020-2025)
Figure 32. North America Blood Product Revenue Market Share by Application (2020-2025)
Figure 33. Asia-Pacific Blood Product Revenue 2020-2031 (US$ Million)
Figure 34. Asia-Pacific Blood Product Revenue Market Share by Region (2020-2031)
Figure 35. Asia-Pacific Blood Product Revenue Market Share by Type (2020-2025)
Figure 36. Asia-Pacific Blood Product Revenue Market Share by Application (2020-2025)
Figure 37. Europe Blood Product Revenue Growth Rate 2020-2031 (US$ Million)
Figure 38. Europe Blood Product Revenue Market Share by Country (2020-2031)
Figure 39. Europe Blood Product Revenue Market Share by Type (2020-2025)
Figure 40. Europe Blood Product Revenue Market Share by Application (2020-2025)
Figure 41. Latin America Blood Product Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Latin America Blood Product Revenue Market Share by Country (2020-2031)
Figure 43. Latin America Blood Product Revenue Market Share by Type (2020-2025)
Figure 44. Latin America Blood Product Revenue Market Share by Application (2020-2025)
Figure 45. Middle East and Africa Blood Product Revenue Growth Rate 2020-2031 (US$ Million)
Figure 46. Middle East and Africa Blood Product Revenue Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Blood Product Revenue Market Share by Type (2020-2025)
Figure 48. Middle East and Africa Blood Product Revenue Market Share by Application (2020-2025)
Figure 49. Blood Product Supply Chain (Upstream and Downstream Market)
Figure 50. Global Production Market Share of Blood Product Raw Materials by Region in 2024
Figure 51. Blood Product Distribution Channels
Figure 52. Global Blood Product Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 53. Global Blood Product Percentage 2020-2031: Online Sales VS Offline Sales
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Table 1. Global Blood Product Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Blood Product Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Blood Product Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Blood Product Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Blood Product Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Blood Product Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Blood Product Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Blood Product Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Blood Product Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Blood Product Revenue by Company (2020-2025) & (US$ Million)
Table 11. Blood Product Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Blood Product Players by Revenue (US$ Million) in 2024
Table 13. Global Blood Product Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Blood Product by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Product as of 2024)
Table 15. Global Blood Product Companies Headquarters
Table 16. Date of International Companies Enter into Blood Product Market
Table 17. Global Blood Product Companies Product & Service
Table 18. Global Blood Product Mergers & Acquisitions, Expansion Plans
Table 19. Takeda Corporation Information
Table 20. Takeda Description and Business Overview
Table 21. Takeda Blood Product Product
Table 22. Takeda Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Takeda Revenue Proportion of Blood Product by Product in 2024
Table 24. Takeda Revenue Proportion of Blood Product by Application in 2024
Table 25. Takeda Revenue Proportion of Blood Product by Geographic Area in 2024
Table 26. Takeda Recent Developments
Table 27. CSL Corporation Information
Table 28. CSL Description and Business Overview
Table 29. CSL Blood Product Product
Table 30. CSL Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. CSL Revenue Proportion of Blood Product by Product in 2024
Table 32. CSL Revenue Proportion of Blood Product by Application in 2024
Table 33. CSL Revenue Proportion of Blood Product by Geographic Area in 2024
Table 34. CSL Recent Developments
Table 35. Grifols Corporation Information
Table 36. Grifols Description and Business Overview
Table 37. Grifols Blood Product Product
Table 38. Grifols Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Grifols Revenue Proportion of Blood Product by Product in 2024
Table 40. Grifols Revenue Proportion of Blood Product by Application in 2024
Table 41. Grifols Revenue Proportion of Blood Product by Geographic Area in 2024
Table 42. Grifols Recent Developments
Table 43. Octapharma Corporation Information
Table 44. Octapharma Description and Business Overview
Table 45. Octapharma Blood Product Product
Table 46. Octapharma Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Octapharma Revenue Proportion of Blood Product by Product in 2024
Table 48. Octapharma Revenue Proportion of Blood Product by Application in 2024
Table 49. Octapharma Revenue Proportion of Blood Product by Geographic Area in 2024
Table 50. Octapharma Recent Developments
Table 51. Kedrion Corporation Information
Table 52. Kedrion Description and Business Overview
Table 53. Kedrion Blood Product Product
Table 54. Kedrion Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Kedrion Revenue Proportion of Blood Product by Product in 2024
Table 56. Kedrion Revenue Proportion of Blood Product by Application in 2024
Table 57. Kedrion Revenue Proportion of Blood Product by Geographic Area in 2024
Table 58. Kedrion Recent Developments
Table 59. LFB Group Corporation Information
Table 60. LFB Group Description and Business Overview
Table 61. LFB Group Blood Product Product
Table 62. LFB Group Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. LFB Group Revenue Proportion of Blood Product by Product in 2024
Table 64. LFB Group Revenue Proportion of Blood Product by Application in 2024
Table 65. LFB Group Revenue Proportion of Blood Product by Geographic Area in 2024
Table 66. LFB Group Recent Developments
Table 67. Biotest Corporation Information
Table 68. Biotest Description and Business Overview
Table 69. Biotest Blood Product Product
Table 70. Biotest Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Biotest Revenue Proportion of Blood Product by Product in 2024
Table 72. Biotest Revenue Proportion of Blood Product by Application in 2024
Table 73. Biotest Revenue Proportion of Blood Product by Geographic Area in 2024
Table 74. Biotest Recent Developments
Table 75. BPL Corporation Information
Table 76. BPL Description and Business Overview
Table 77. BPL Blood Product Product
Table 78. BPL Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. BPL Revenue Proportion of Blood Product by Product in 2024
Table 80. BPL Revenue Proportion of Blood Product by Application in 2024
Table 81. BPL Revenue Proportion of Blood Product by Geographic Area in 2024
Table 82. BPL Recent Developments
Table 83. RAAS Corporation Information
Table 84. RAAS Description and Business Overview
Table 85. RAAS Blood Product Product
Table 86. RAAS Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. RAAS Revenue Proportion of Blood Product by Product in 2024
Table 88. RAAS Revenue Proportion of Blood Product by Application in 2024
Table 89. RAAS Revenue Proportion of Blood Product by Geographic Area in 2024
Table 90. RAAS Recent Developments
Table 91. CBPO Corporation Information
Table 92. CBPO Description and Business Overview
Table 93. CBPO Blood Product Product
Table 94. CBPO Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. CBPO Revenue Proportion of Blood Product by Product in 2024
Table 96. CBPO Revenue Proportion of Blood Product by Application in 2024
Table 97. CBPO Revenue Proportion of Blood Product by Geographic Area in 2024
Table 98. CBPO Recent Developments
Table 99. Hualan Bio Corporation Information
Table 100. Hualan Bio Description and Business Overview
Table 101. Hualan Bio Blood Product Product
Table 102. Hualan Bio Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Hualan Bio Revenue Proportion of Blood Product by Product in 2024
Table 104. Hualan Bio Revenue Proportion of Blood Product by Application in 2024
Table 105. Hualan Bio Revenue Proportion of Blood Product by Geographic Area in 2024
Table 106. Hualan Bio Recent Developments
Table 107. Tiantan Bio Corporation Information
Table 108. Tiantan Bio Description and Business Overview
Table 109. Tiantan Bio Blood Product Product
Table 110. Tiantan Bio Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. Tiantan Bio Revenue Proportion of Blood Product by Product in 2024
Table 112. Tiantan Bio Revenue Proportion of Blood Product by Application in 2024
Table 113. Tiantan Bio Revenue Proportion of Blood Product by Geographic Area in 2024
Table 114. Tiantan Bio Recent Developments
Table 115. Shuanglin Bio Corporation Information
Table 116. Shuanglin Bio Description and Business Overview
Table 117. Shuanglin Bio Blood Product Product
Table 118. Shuanglin Bio Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. Shuanglin Bio Revenue Proportion of Blood Product by Product in 2024
Table 120. Shuanglin Bio Revenue Proportion of Blood Product by Application in 2024
Table 121. Shuanglin Bio Revenue Proportion of Blood Product by Geographic Area in 2024
Table 122. Shuanglin Bio Recent Developments
Table 123. Boya Bio Corporation Information
Table 124. Boya Bio Description and Business Overview
Table 125. Boya Bio Blood Product Product
Table 126. Boya Bio Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
Table 127. Boya Bio Revenue Proportion of Blood Product by Product in 2024
Table 128. Boya Bio Revenue Proportion of Blood Product by Application in 2024
Table 129. Boya Bio Revenue Proportion of Blood Product by Geographic Area in 2024
Table 130. Boya Bio Recent Developments
Table 131. Yuanda Shuyang Corporation Information
Table 132. Yuanda Shuyang Description and Business Overview
Table 133. Yuanda Shuyang Blood Product Product
Table 134. Yuanda Shuyang Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
Table 135. Yuanda Shuyang Revenue Proportion of Blood Product by Product in 2024
Table 136. Yuanda Shuyang Revenue Proportion of Blood Product by Application in 2024
Table 137. Yuanda Shuyang Revenue Proportion of Blood Product by Geographic Area in 2024
Table 138. Yuanda Shuyang Recent Developments
Table 139. Weiguang Bio Corporation Information
Table 140. Weiguang Bio Description and Business Overview
Table 141. Weiguang Bio Blood Product Product
Table 142. Weiguang Bio Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. Weiguang Bio Revenue Proportion of Blood Product by Product in 2024
Table 144. Weiguang Bio Revenue Proportion of Blood Product by Application in 2024
Table 145. Weiguang Bio Revenue Proportion of Blood Product by Geographic Area in 2024
Table 146. Weiguang Bio Recent Developments
Table 147. Nanyue Bio Corporation Information
Table 148. Nanyue Bio Description and Business Overview
Table 149. Nanyue Bio Blood Product Product
Table 150. Nanyue Bio Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
Table 151. Nanyue Bio Revenue Proportion of Blood Product by Product in 2024
Table 152. Nanyue Bio Revenue Proportion of Blood Product by Application in 2024
Table 153. Nanyue Bio Revenue Proportion of Blood Product by Geographic Area in 2024
Table 154. Nanyue Bio Recent Developments
Table 155. KM Biologics Corporation Information
Table 156. KM Biologics Description and Business Overview
Table 157. KM Biologics Blood Product Product
Table 158. KM Biologics Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
Table 159. KM Biologics Revenue Proportion of Blood Product by Product in 2024
Table 160. KM Biologics Revenue Proportion of Blood Product by Application in 2024
Table 161. KM Biologics Revenue Proportion of Blood Product by Geographic Area in 2024
Table 162. KM Biologics Recent Developments
Table 163. North America Blood Product Revenue by Country (2020-2025) & (US$ Million)
Table 164. North America Blood Product Revenue by Country (2026-2031) & (US$ Million)
Table 165. North America Blood Product Revenue by Type (2020-2025) & (US$ Million)
Table 166. North America Blood Product Revenue by Application (2020-2025) & (US$ Million)
Table 167. Asia-Pacific Blood Product Revenue by Region (2020-2025) & (US$ Million)
Table 168. Asia-Pacific Blood Product Revenue by Region (2026-2031) & (US$ Million)
Table 169. Asia-Pacific Blood Product Revenue by Type (2020-2025) & (US$ Million)
Table 170. Asia-Pacific Blood Product Revenue by Application (2020-2025) & (US$ Million)
Table 171. Europe Blood Product Revenue by Country (2020-2025) & (US$ Million)
Table 172. Europe Blood Product Revenue by Country (2026-2031) & (US$ Million)
Table 173. Europe Blood Product Revenue by Type (2020-2025) & (US$ Million)
Table 174. Europe Blood Product Revenue by Application (2020-2025) & (US$ Million)
Table 175. Latin America Blood Product Revenue by Country (2020-2025) & (US$ Million)
Table 176. Latin America Blood Product Revenue by Country (2026-2031) & (US$ Million)
Table 177. Latin America Blood Product Revenue by Type (2020-2025) & (US$ Million)
Table 178. Latin America Blood Product Revenue by Application (2020-2025) & (US$ Million)
Table 179. Middle East and Africa Blood Product Revenue by Country (2020-2025) & (US$ Million)
Table 180. Middle East and Africa Blood Product Revenue by Country (2026-2031) & (US$ Million)
Table 181. Middle East and Africa Blood Product Revenue by Type (2020-2025) & (US$ Million)
Table 182. Middle East and Africa Blood Product Revenue by Application (2020-2025) & (US$ Million)
Table 183. Blood Product Key Raw Materials, Industry Status and Trend
Table 184. Blood Product Key Raw Materials and Upstream Suppliers
Table 185. Blood Product Clients Status and Trend
Table 186. Blood Product Typical Clients
Table 187. Blood Product Distributors
Table 188. Blood Product Market Trends
Table 189. Blood Product Market Drivers
Table 190. Blood Product Market Challenges
Table 191. Blood Product Market Restraints
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
List of Figures
Figure 1. Blood Product Product Picture
Figure 2. Global Blood Product Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Blood Product Revenue Market Share by Type in 2024 & 2031
Figure 4. Albumin Product Picture
Figure 5. Immunoglobulin Product Picture
Figure 6. Clotting Factor Product Picture
Figure 7. Others Product Picture
Figure 8. Global Blood Product Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 9. Global Blood Product Revenue Market Share by Application in 2024 & 2031
Figure 10. Hospital
Figure 11. Retail Pharmacy
Figure 12. Other
Figure 13. Blood Product Report Years Considered
Figure 14. Global Blood Product Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Blood Product Market Size (2020-2031) & (US$ Million)
Figure 16. Global Blood Product Market Size Market Share by Region: 2024 Versus 2031
Figure 17. Global Blood Product Revenue Market Share by Region (2020-2031)
Figure 18. Global Blood Product Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Global Blood Product Revenue Market Share Forecast by Application (2020-2031)
Figure 20. Albumin of Blood Product Revenue Market Share by Application, 2024 VS 2031
Figure 21. Immunoglobulin of Blood Product Revenue Market Share by Application, 2024 VS 2031
Figure 22. Clotting Factor of Blood Product Revenue Market Share by Application, 2024 VS 2031
Figure 23. Others of Blood Product Revenue Market Share by Application, 2024 VS 2031
Figure 24. Blood Product Revenue Share by Company (2024)
Figure 25. Blood Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. Albumin Revenue Proportion by Company in 2024
Figure 27. Immunoglobulin Revenue Proportion by Company in 2024
Figure 28. Clotting Factor Revenue Proportion by Company in 2024
Figure 29. Others Revenue Proportion by Company in 2024
Figure 30. North America Blood Product Revenue 2020-2031 (US$ Million)
Figure 31. North America Blood Product Revenue Market Share by Type (2020-2025)
Figure 32. North America Blood Product Revenue Market Share by Application (2020-2025)
Figure 33. Asia-Pacific Blood Product Revenue 2020-2031 (US$ Million)
Figure 34. Asia-Pacific Blood Product Revenue Market Share by Region (2020-2031)
Figure 35. Asia-Pacific Blood Product Revenue Market Share by Type (2020-2025)
Figure 36. Asia-Pacific Blood Product Revenue Market Share by Application (2020-2025)
Figure 37. Europe Blood Product Revenue Growth Rate 2020-2031 (US$ Million)
Figure 38. Europe Blood Product Revenue Market Share by Country (2020-2031)
Figure 39. Europe Blood Product Revenue Market Share by Type (2020-2025)
Figure 40. Europe Blood Product Revenue Market Share by Application (2020-2025)
Figure 41. Latin America Blood Product Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Latin America Blood Product Revenue Market Share by Country (2020-2031)
Figure 43. Latin America Blood Product Revenue Market Share by Type (2020-2025)
Figure 44. Latin America Blood Product Revenue Market Share by Application (2020-2025)
Figure 45. Middle East and Africa Blood Product Revenue Growth Rate 2020-2031 (US$ Million)
Figure 46. Middle East and Africa Blood Product Revenue Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Blood Product Revenue Market Share by Type (2020-2025)
Figure 48. Middle East and Africa Blood Product Revenue Market Share by Application (2020-2025)
Figure 49. Blood Product Supply Chain (Upstream and Downstream Market)
Figure 50. Global Production Market Share of Blood Product Raw Materials by Region in 2024
Figure 51. Blood Product Distribution Channels
Figure 52. Global Blood Product Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 53. Global Blood Product Percentage 2020-2031: Online Sales VS Offline Sales
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232